Busca avançada
Ano de início
Entree


The future of aplastic anemia treatment in Brazil: Lessons learned for global hematology

Texto completo
Autor(es):
Calado, Rodrigo T.
Número total de Autores: 1
Tipo de documento: Artigo Científico
Fonte: SEMINARS IN HEMATOLOGY; v. 60, n. 4, p. 4-pg., 2023-11-14.
Resumo

Aplastic anemia (AA) is a rare serious hematologic disorder caused by hematopoietic stem cell failure in maintaining hematopoiesis. AA is virtually fatal if not treated, and diagnosis and therapy require exten-sive hematologic infrastructure. Academic medical centers in Brazil have continuously and significantly contributed to diagnostic tools and therapy development, from novel transplant strategies to drug com-binations and implementation science in the national public health system. In the present review, we discuss how the collaborative effort among academic centers in hematology has contributed to improv-ing health care for patients with aplastic anemia. We also discuss what needs are still unmet and how to overcome these challenges.(c) 2023 Elsevier Inc. All rights reserved. (AU)

Processo FAPESP: 13/08135-2 - CTC - Centro de Terapia Celular
Beneficiário:Dimas Tadeu Covas
Modalidade de apoio: Auxílio à Pesquisa - Centros de Pesquisa, Inovação e Difusão - CEPIDs
Processo FAPESP: 19/17520-3 - Perfil imunológico das telomeropatias
Beneficiário:Rodrigo do Tocantins Calado de Saloma Rodrigues
Modalidade de apoio: Auxílio à Pesquisa - Regular